Cellnovo rides storms to €30m diabetes IPO
Whether investors can look past the turmoil around Greece at a promising growth story was tested this week, as Cellnovo attempted to float in Paris. The test was passed: the IPO was priced on Thursday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts